微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 21% | -14.27% | -7.74% | 44/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 22.76% | -11.48% | 3.89% | 43/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 21.91% | -24.67% | 5.31% | 41/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 20.8% | -51.21% | -15.07% | 45/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 24.49% | -44.03% | -4.73% | 44/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 25.71% | -45.03% | -11.59% | 43/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 29.08% | -39.36% | -31.79% | 41/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 42.64% | 11.52% | -2.58% | 23/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 43.76% | 11.3% | -6.43% | 23/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 46.77% | 22.74% | -2.48% | 17/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 47.96% | 2% | 25.44% | 12/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 38.23% | 18.4% | -2.77% | 37/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 39.32% | 2% | 3.19% | 25/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 38.11% | 14.36% | 18% | 31/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2020-12-31 | 32.29% | 6.89% | -3.09% | 41/51 | 38.51% | 南华生物 | 83.9% | 行业排名> |
| 2020-06-30 | 33.32% | 5.29% | 10.3% | 29/51 | 39.28% | 成都先导 | 79.36% | 行业排名> |
| 2019-12-31 | 30.21% | -2.11% | -2.11% | 43/51 | 42.94% | 成都先导 | 75.92% | 行业排名> |
| 2018-12-31 | 30.86% | 2.21% | 2.21% | 41/51 | 42.09% | 南华生物 | 78.74% | 行业排名> |
| 2017-12-31 | 30.19% | -9.99% | -4.59% | 35/51 | 40.94% | 成都先导 | 80.82% | 行业排名> |
| 2017-06-30 | 31.65% | -22.48% | -5.66% | 23/51 | 43.6% | 成都先导 | 81.55% | 行业排名> |
| 2016-12-31 | 33.55% | -4.4% | -17.83% | 23/51 | 40.43% | 海特生物 | 84.37% | 行业排名> |
| 2016-06-30 | 40.83% | 2% | 16.34% | 11/51 | 33.77% | 海特生物 | 87.74% | 行业排名> |
| 2015-12-31 | 35.09% | 13.35% | 13.35% | 16/51 | 37.17% | 海特生物 | 88.04% | 行业排名> |